Aflac
Price: 117.11Company and Business Model
Aflac is a financial services company primarily focused on supplemental insurance products. Its core offerings include accident, cancer, critical illness, and short-term disability insurance. The company operates mainly in the United States and Japan, with significant revenue generated from premiums and investment income. Aflac is recognized for its strong brand presence in the supplemental insurance market, catering to both individual and group policyholders.
Investment Profile
Aflac's stock may appeal to investors seeking dividends, given its consistent dividend yield. The company's focus on supplemental insurance positions it as a stable player in the financial sector, though recent revenue declines may indicate challenges. This stock is suitable for those looking for a balanced investment approach, considering its dividend payments alongside potential for moderate growth.
Fundamental metrics (experimental)
- EPS (TTM) — earnings per share for the last 12 months, $
- 8.80 OK
- Revenue QoQ — quarter-over-quarter revenue growth
- -11.9% ↓
- EPS surprise
- -2.2% in line
- 20d volatility
- 1.2% stable
- Dividend yield
- 2.1% moderate last ex-date: 2026-05-20
Forecast impact
limitedTrack in portfolio
Price chart
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-06-05 02:53 | Sell | Hold | Mixed fundamentals with moderate momentum; hold for stability. |
| 2026-05-28 03:38 | Buy | Sell | Weak fundamentals and negative momentum raise concerns. |
| 2026-05-22 02:34 | Hold | Buy | Mixed signals; monitor fundamentals and market conditions closely. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-05-26 10:44 | Piper Sandler | Target Raised | 125 → 130 | 117.86 |
| 2026-05-21 12:05 | Morgan Stanley | Target Raised | 120 → 125 | 117.3 |
| 2026-05-04 11:44 | Mizuho Securities | Target Raised | 102 → 104 | 112.88 |
Nothing yet